Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

[New developments in topical pharmaceuticals].

Wohlrab J.

Hautarzt. 2019 Nov 11. doi: 10.1007/s00105-019-04505-1. [Epub ahead of print] Review. German.

PMID:
31712975
2.

[Basics of the pharmacology of biopharmaceuticals].

Wohlrab J.

Hautarzt. 2019 Nov 11. doi: 10.1007/s00105-019-04502-4. [Epub ahead of print] Review. German.

PMID:
31712972
3.

Clinical Applications of Hyaluronidase.

Weber GC, Buhren BA, Schrumpf H, Wohlrab J, Gerber PA.

Adv Exp Med Biol. 2019;1148:255-277. doi: 10.1007/978-981-13-7709-9_12. Review.

PMID:
31482503
4.

Sterile transiente neonatale Pustulose - Überlappung einer transienten neonatalen pustulösen Melanose mit einem Erythema toxicum neonatorum.

Michl C, Wohlrab J.

J Dtsch Dermatol Ges. 2019 Jul;17(7):731-732. doi: 10.1111/ddg.13860_g. No abstract available.

PMID:
31364294
5.

Pathomechanism of dupilumab-associated inflammatory eye symptoms.

Wohlrab J, Werfel T, Wollenberg A.

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e435-e436. doi: 10.1111/jdv.15755. Epub 2019 Jul 3. No abstract available.

PMID:
31220376
6.

Sterile transient neonatal pustulosis - overlap between transient neonatal pustular melanosis and erythema toxicum neonatorum.

Michl C, Wohlrab J.

J Dtsch Dermatol Ges. 2019 Jul;17(7):731-732. doi: 10.1111/ddg.13860. Epub 2019 May 27. No abstract available.

PMID:
31131958
7.

Quantitative Analysis of Free Amino Acids and Urea Derived from Isolated Corneocytes of Healthy Young, Healthy Aged, and Diseased Skin.

Hussain H, Ziegler J, Hause G, Wohlrab J, Neubert RHH.

Skin Pharmacol Physiol. 2019;32(2):94-100. doi: 10.1159/000495992. Epub 2019 Feb 15.

PMID:
30783061
8.

90. Jahrestagung der Norddeutschen Dermatologischen Gesellschaft.

Panzer R, Sander, Wohlrab J, Tronnier M.

J Dtsch Dermatol Ges. 2018 Dec;16(12):1513-1514. doi: 10.1111/ddg.13690. No abstract available.

PMID:
30537322
9.

[Interdisciplinary recommendations for action in dupilumab-related inflammatory eye diseases].

Wohlrab J, Wollenberg A, Reimann H, Pleyer U, Werfel T.

Hautarzt. 2019 Jan;70(1):64-67. doi: 10.1007/s00105-018-4316-1. Review. German. No abstract available.

PMID:
30478601
10.

Cryopyrin-assoziiertes periodisches Syndrom (CAPS) bei T348M-Mutation im NLRP3-Gen.

Kreft B, Schlinsog AS, Wohlrab J.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1266-1268. doi: 10.1111/ddg.13654_g. No abstract available.

PMID:
30300489
11.

[Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Wohlrab J, Kreft B.

Hautarzt. 2018 Oct;69(10):857-869. doi: 10.1007/s00105-018-4265-8. German.

PMID:
30218113
12.

Cryopyrin-associated periodic syndrome (CAPS) in a patient with NLRP3 T348M mutation.

Kreft B, Schlinsog AS, Wohlrab J.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1266-1268. doi: 10.1111/ddg.13654. Epub 2018 Sep 5. No abstract available.

PMID:
30184330
13.

Dermal peptide delivery using enhancer molecules and colloidal carrier systems. Part III: Tetrapeptide GEKG.

Sommer E, Neubert RHH, Mentel M, Tuchscherer B, Mrestani Y, Wohlrab J.

Eur J Pharm Sci. 2018 Nov 1;124:137-144. doi: 10.1016/j.ejps.2018.08.034. Epub 2018 Aug 27.

PMID:
30165235
14.

Age- and Diabetes-Related Changes in the Free Fatty Acid Composition of the Human Stratum Corneum.

Wohlrab J, Gabel A, Wolfram M, Grosse I, Neubert RHH, Steinbach SC.

Skin Pharmacol Physiol. 2018;31(6):283-291. doi: 10.1159/000490800. Epub 2018 Aug 21.

PMID:
30130788
15.

pH and Buffer Capacity of Topical Formulations.

Wohlrab J, Gebert A.

Curr Probl Dermatol. 2018;54:123-131. doi: 10.1159/000489526. Epub 2018 Aug 21.

PMID:
30130781
16.

Lipids in the Skin and pH.

Wohlrab J, Gebert A, Neubert RHH.

Curr Probl Dermatol. 2018;54:64-70. doi: 10.1159/000489519. Epub 2018 Aug 21. Review.

PMID:
30130772
17.

Development and validation of LC/APCI-MS method for the quantification of oat ceramides in skin permeation studies.

Tessema EN, Gebre-Mariam T, Frolov A, Wohlrab J, Neubert RHH.

Anal Bioanal Chem. 2018 Aug;410(20):4775-4785. doi: 10.1007/s00216-018-1162-z. Epub 2018 Jun 9.

PMID:
29947900
18.

S2k guidelines for the use of topical preparations on the skin.

Wohlrab J, Staubach P, Augustin M, Eisert L, Hünerbein A, Nast A, Reimann H, Strömer K, Mahler V.

J Dtsch Dermatol Ges. 2018 Mar;16(3):376-392. doi: 10.1111/ddg.13473.

PMID:
29537159
19.

S2k-Leitlinie zum Gebrauch von Präparationen zur lokalen Anwendung auf der Haut (Topika).

Wohlrab J, Staubach P, Augustin M, Eisert L, Hünerbein A, Nast A, Reimann H, Strömer K, Mahler V.

J Dtsch Dermatol Ges. 2018 Mar;16(3):376-392. doi: 10.1111/ddg.13473_g.

PMID:
29537157
20.

Leserbrief zu Solomonidou I et al. "Asymptomatische erythematös-livide skrotale Vesiculae bei einem 78-jährigem Patienten". J Dtsch Dermatol Ges 2017; 15: 853-5.

Marsch WC, Wohlrab J.

J Dtsch Dermatol Ges. 2018 Mar;16(3):355-356. doi: 10.1111/ddg.13439. No abstract available.

PMID:
29537154
21.

Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: Formulation, characterization and in vitro and ex-vivo penetration studies.

Tessema EN, Gebre-Mariam T, Paulos G, Wohlrab J, Neubert RHH.

Eur J Pharm Biopharm. 2018 Jun;127:260-269. doi: 10.1016/j.ejpb.2018.02.037. Epub 2018 Mar 6.

PMID:
29501672
22.

Retarder action of isosorbide in a microemulsion for a targeted delivery of ceramide NP into the stratum corneum.

Steinbach SC, Triani R, Bennedsen L, Gabel A, Haeusler O, Wohlrab J, Neubert RHH.

Pharmazie. 2017 Aug 1;72(8):440-446. doi: 10.1691/ph.2017/7004.

PMID:
29441901
23.

Dapson für die topische Therapie in magistralen Rezepturen.

Wohlrab J, Michael J.

J Dtsch Dermatol Ges. 2018 Jan;16(1):34-41. doi: 10.1111/ddg.13409_g. No abstract available.

PMID:
29314675
24.

Dapsone for topical use in extemporaneous preparations.

Wohlrab J, Michael J.

J Dtsch Dermatol Ges. 2018 Jan;16(1):34-40. doi: 10.1111/ddg.13409. Epub 2017 Dec 27.

PMID:
29280553
25.

Dermal peptide delivery using enhancer moleculs and colloidal carrier systems. Part II: Tetrapeptide PKEK.

Neubert RHH, Sommer E, Schölzel M, Tuchscherer B, Mrestani Y, Wohlrab J.

Eur J Pharm Biopharm. 2018 Mar;124:28-33. doi: 10.1016/j.ejpb.2017.12.004. Epub 2017 Dec 14.

PMID:
29247690
26.

[Paresthesia and swollen condition of the tongue].

Wohlrab J, Gebert A.

Hautarzt. 2018 Mar;69(3):260-262. doi: 10.1007/s00105-017-4060-y. German. No abstract available.

PMID:
29022060
27.

Dermal and transdermal delivery of pharmaceutically relevant macromolecules.

Münch S, Wohlrab J, Neubert RHH.

Eur J Pharm Biopharm. 2017 Oct;119:235-242. doi: 10.1016/j.ejpb.2017.06.019. Epub 2017 Jun 21. Review.

PMID:
28647443
28.

Potential Applications of Phyto-Derived Ceramides in Improving Epidermal Barrier Function.

Tessema EN, Gebre-Mariam T, Neubert RHH, Wohlrab J.

Skin Pharmacol Physiol. 2017;30(3):115-138. doi: 10.1159/000464337. Epub 2017 Apr 14. Review.

29.

[Topical therapy of the scalp].

Wohlrab J, Michael J.

Hautarzt. 2017 Jun;68(6):478-482. doi: 10.1007/s00105-017-3963-y. Review. German.

PMID:
28283686
30.

[Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].

Wohlrab J, Neubert RH, Sommer E, Michael J.

Hautarzt. 2017 Apr;68(4):307-315. doi: 10.1007/s00105-016-3926-8. German.

PMID:
28091698
31.

[Preclinical safety evaluation of chloral hydrate after topical application using the example of psoriatic itch].

Wohlrab J, Gilbrich F, Wolff L, Fischer M, Philipp S.

Hautarzt. 2017 Mar;68(3):217-223. doi: 10.1007/s00105-016-3909-9. German.

PMID:
27981385
32.

Ex vivo Cutaneous Bioavailability of Topical Mometasone Furoate in an O/W Preparation.

Wohlrab J, Neubert RH, Sommer E, Michael J.

Skin Pharmacol Physiol. 2016;29(5):273-279. doi: 10.1159/000452743. Epub 2016 Dec 8.

33.

Topika und deren Einsatz in der Dermatologie.

Wohlrab J.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1061-1071. doi: 10.1111/ddg.13151_g.

PMID:
27879100
34.

Topical preparations and their use in dermatology.

Wohlrab J.

J Dtsch Dermatol Ges. 2016 Nov;14(11):1061-1070. doi: 10.1111/ddg.13151. Review.

PMID:
27879084
35.

Controlled Penetration of a Novel Dimeric Ceramide into and across the Stratum Corneum Using Microemulsions and Various Types of Semisolid Formulations.

Neubert RH, Sonnenberger S, Dobner B, Gray CW Jr, Barger KN, Sevi-Maxwell K, Sommer E, Wohlrab J.

Skin Pharmacol Physiol. 2016;29(3):130-4. doi: 10.1159/000445776. Epub 2016 May 19.

36.

Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.

Menter MA, Papp KA, Cather J, Leonardi C, Pariser DM, Krueger JG, Wohlrab J, Amaya-Guerra M, Kaszuba A, Nadashkevich O, Tsai TF, Gupta P, Tan H, Valdez H, Mallbris L, Tatulych S.

J Drugs Dermatol. 2016 May 1;15(5):568-80.

PMID:
27168266
37.

Preclinical and clinical characterization of the cutaneous bioavailability of the hydrophilic phase of a water-in-oil emulsion.

Wohlrab J, Richter C, Stauder S.

J Dtsch Dermatol Ges. 2016 Jul;14(7):698-705. doi: 10.1111/ddg.12732. Epub 2015 Dec 4.

PMID:
26636922
38.

[Epidermal aging and anti-aging strategies].

Wohlrab J, Hilpert K, Wolff L.

Hautarzt. 2016 Feb;67(2):107-11. doi: 10.1007/s00105-015-3734-6. Review. German.

PMID:
26636143
39.

[Erythema and swelling after im-plantation of a cardioverter defibrillator (ICD)].

Kreft B, Thomas P, Steinhauser E, Vass A, Summer B, Wohlrab J.

Dtsch Med Wochenschr. 2015 Sep;140(19):1462-4. doi: 10.1055/s-0041-105574. Epub 2015 Sep 24. German.

PMID:
26402185
40.

Methotrexate for topical application in an extemporaneous preparation.

Wohlrab J, Neubert RH, Michael J, Naumann S.

J Dtsch Dermatol Ges. 2015 Sep;13(9):891-901. doi: 10.1111/ddg.12622. Epub 2015 Aug 18.

PMID:
26284814
41.

Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis.

Radtke MA, Mrowietz U, Feuerhahn J, Härter M, von Kiedrowski R, Nast A, Reich K, Strömer K, Wohlrab J, Augustin M.

J Dtsch Dermatol Ges. 2015 Jul;13(7):674-90. doi: 10.1111/ddg.12643. Epub 2015 Jun 15. English, German.

PMID:
26075502
42.

Pharmacokinetic characteristics of therapeutic antibodies.

Wohlrab J.

J Dtsch Dermatol Ges. 2015 Jun;13(6):530-4. doi: 10.1111/ddg.12648. Review. English, German.

PMID:
26018364
43.

Cutaneous drug delivery of capsaicin after in vitro administration of the 8% capsaicin dermal patch system.

Wohlrab J, Neubert RH, Heskamp ML, Michael J.

Skin Pharmacol Physiol. 2015;28(2):65-74. doi: 10.1159/000362740. Epub 2014 Sep 23.

PMID:
25277470
44.

[Characteristics of aging skin].

Wohlrab J, Hilpert K, Wohlrab A.

Hautarzt. 2014 Oct;65(10):911-20; quiz 921-2. doi: 10.1007/s00105-014-3506-8. German.

PMID:
25231590
45.

Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy.

Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RH.

Skin Pharmacol Physiol. 2015;28(1):42-55. doi: 10.1159/000360009. Epub 2014 Aug 29. Review.

46.

Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer.

Wohlrab J, Bangemann N, Kleine-Tebbe A, Thill M, Kümmel S, Grischke EM, Richter R, Seite S, Lüftner D.

Breast Cancer (Dove Med Press). 2014 Aug 1;6:115-22. doi: 10.2147/BCTT.S61699. eCollection 2014.

47.

Niacinamide - mechanisms of action and its topical use in dermatology.

Wohlrab J, Kreft D.

Skin Pharmacol Physiol. 2014;27(6):311-5. doi: 10.1159/000359974. Epub 2014 Jun 27. Review.

PMID:
24993939
48.

Use of hyaluronidase for pharmacokinetic increase in bioavailability of intracutaneously applied substances.

Wohlrab J, Wohlrab D, Wohlrab L, Wohlrab C, Wohlrab A.

Skin Pharmacol Physiol. 2014;27(5):276-82. doi: 10.1159/000360545. Epub 2014 Jun 18. Review.

PMID:
24944044
49.

[Regulatory requirements for topical preparations].

Wohlrab J, Klauck D, Savtcheva E.

Hautarzt. 2014 Mar;65(3):175-9. doi: 10.1007/s00105-013-2655-5. German.

PMID:
24622851
50.

[Future of topical therapy].

Wohlrab J, Staubach P.

Hautarzt. 2014 Mar;65(3):168. doi: 10.1007/s00105-013-2661-7. German. No abstract available.

PMID:
24622850

Supplemental Content

Loading ...
Support Center